Tennant R., Wiggers CJ: The effect of coronary occlusion on myocardial contraction. Amer J Physiol211: 351-361, 1935
2.
Kones RJ: The equivalent electrical circuit of the myocardial membrane. Submitted for publication
3.
Herman MV, Gorlin R.: Implications of left ventricular asynergy. Amer J Cardiol23: 538-547, 1969
4.
Braunwald E., Ross J. Jr, Sonnenblick EH: Mechanisms of Contraction of the Normal and Failing Heart. Boston, Little Brown & Co., 1968
5.
Kones RJ: The molecular and ionic basis of altered myocardial contractility. Res Commun Chem Pathol Pharmacol5(suppl 1): 1-86, 1973
6.
Braunwald E. : Mechanics and energetics of the normal and failing heart. Trans Assn Amer Phys84: 63-94, 1971
7.
Mueller H., Ayres SM, Gianelli S.Jr, et al: Cardiac performance and metabolism in shock due to acute myocardial infarction in man: response to catecholamines and mechanical cardiac assist . Trans NY Acad Sci34: 309-333, 1972
8.
Ratshin RA, Rackley CE, Russell RO: Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction. Circulation45: 127-139, 1972
9.
Diamond G., Forrester JS: Effect of coronary artery disease and acute myocardial infarction on left ventricular compliance in man. Circulation45: 11-19, 1972
10.
Forrester JS , Diamond G., McHugh TJ, et al: Filling pressure in the right and left side of the heart in acute myocardial infarction. A reappraisal of central venous pressure monitoring. New Eng J Med285: 190-193, 1971
11.
Kones RJ: Oxygen therapy for acute myocardial infarction: basis for a practical approach . Southern Med J: In press
12.
Prakash R., Parmley WW, Horvat M., et al: Serum cortisol, plasma free fatty acids, and urinary catecholamines as indicators of complications in acute myocardial infarction. Circulation45: 736-745, 1972
13.
Kones RJ: Are corticosteroids in large doses beneficial in treating cardiogenic shock?Jap Heart J14: 1973
14.
Braunwald E. , Covell JW, Maroko PR, et al: The effect of drugs and of counterpulsation on myocardial oxygen consumption. Observations on the ischemic heart. Circulation40(suppl IV): 220-228, 1969
15.
Pelides LJ, Reid DS, Thomas M., et al: Inhibition by B-blockade of the ST segment elevation after acute myocardial infarction in man. Cardiovasc Res6: 295-301, 1972
16.
Maroko PR, Kjekshus J., Sobel B., et al: The correlation between myocardial creatine phosphokinase activity and epicardial changes following experimental myocardial infarction. Clin Res18: 116, 1970
17.
Kones RJ, Phillips JH: Glucagon—present status in cardiovascular disease. Clin Pharm Therap12: 427-444, 1971
18.
Kones RJ: El glucagon en la terapia de los sindromes de debito bajo. Rev Med (Chile) 100: 1116-1119, 1972
Kones RJ: Potassium and the heart. Submitted for publication
21.
Majid PA, Sharma B., Meeran Mkm, et al: Insulin and glucose in the treatment of heart-failure. Lancet2: 937-941, 1972
22.
Maroko PR, Libby P., Sobel BE, et al: Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation45: 1160-1175, 1972
23.
Wildenthal K., Crie JS, Vastagh GF: Cardiovascular function and survival during severe systemic hypoxaemia: influence of glucose-potassium-insulin solution and of beta-blockade. Cardiovasc Res7: 174-180, 1973
24.
Moffitt EA: Effects on metabolism and cardiac output of glucose-potassium solution with and without insulin. Ann Thoracic Surg15: 1-15, 1973
25.
Maroko PR, Libby P., Bloor CM, et al: Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation46: 430-437, 1972
